Back to top
more

Fidelity Select Biotechnology: (MF: FBIOX)

(MF) As of Nov 20, 2017 06:05 PM ET

 Add to portfolio

$213.35 USD

-1.35 (-0.63%)

Zacks MF Rank 1-Strong Buy 1        

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Oct 31, 2017

Total Return %* Percentile Rank Objective
YTD 25.84 17
3 months 1.08 34
6 months 7.45 24
1 Year 30.68 15
3 Year 4.61 57
5 Year 20.32 9
10 Year 14.65 5

* Annual for three years and beyond.

Zacks Premium Research for FBIOX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank Strong Buy 1
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 34.00
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 10/31/2017 9,180.38
%Turnover 10/31/2017 28.00

Risk

3 Year 5 Year 10 Year
Beta -7.61 20.80 22.86
Alpha 5.87 30.73 27.00
R Squared 0.00 0.00 0.03
Std. Dev. 28.72 27.07 24.06
Sharpe 0.31 0.91 2.00

Sector / Country Weightings

As of 10/31/2017 % of Portfolio
Health 74.73
Other 13.05
Services 12.02
Industrial Cyclical 0.12
Finance 0.08

Portfolio Holdings

Top Equity Holdings
(As of 8/31/2017)
% of Portfolio Value (Mil$)
AMGEN INC 9.59 946.49
CELGENE CORP 6.06 598.29
REGENERON PHARMACEUTICALS 5.32 525.01
VERTEX PHARMACEUTICALS IN 4.68 461.71
ALEXION PHARMACEUTICALS I 4.64 458.10
BIOGEN INC 3.96 390.31
INCYTE PHARMACEUTICALS IN 2.20 216.91
GILEAD SCIENCES INC 1.72 169.33
PORTOLA PHARMACEUTICALS I 1.71 168.99

Stock Holding % of Net Assets

As Of 8/31/2017
Total Issues 224
Avg. P/E 33.30
Avg. P/Book 5.55
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 35,989

Allocation

% of Portfolio
Large Growth 41.87
Large Value 0.00
Small Growth 0.00
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00